BACKGROUND: The prevalence of atrial fibrillation substantially increases after 70 years of age. However, the effect of rate-control versus rhythm-control strategies on outcomes in these patients remains unclear. METHODS: In the randomized Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial, 4060 patients (mean age 70 years, range 49-80 years) with paroxysmal and persistent atrial fibrillation were randomized to rate-control versus rhythm-control strategies. Of these, 2248 were 70-80 years, of whom 1118 were in the rate-control group. Propensity scores for rate-control strategy were estimated for each of the 2248 patients and were used to assemble a cohort of 937 pairs of patients receiving rate-control versus rhythm-control strategies, balanced on 45 baseline characteristics. RESULTS:Matched patients had a mean age of 75 years; 45% were women, 7% were nonwhite, and 47% had prior hospitalizations due to arrhythmias. During 3.4 years of mean follow-up, all-cause mortality occurred in 18% and 23% of matched patients in the rate-control and rhythm-control groups, respectively (hazard ratio [HR] associated with rate control, 0.77; 95% confidence interval [CI], 0.63-0.94; P = .010). HRs (95% CIs) for cardiovascular and noncardiovascular mortality associated with rate control were 0.88 (0.65-1.18) and 0.62 (0.46-0.84), respectively. All-cause hospitalization occurred in 61% and 68% of rate-control and rhythm-control patients, respectively (HR 0.76; 95% CI, 0.68-0.86). HRs (95% CIs) for cardiovascular and noncardiovascular hospitalization were 0.66 (0.56-0.77) and 1.07 (0.91-1.27), respectively. CONCLUSION: In septuagenarian patients with atrial fibrillation, compared with rhythm-control, a rate-control strategy was associated with significantly lower mortality and hospitalization.
RCT Entities:
BACKGROUND: The prevalence of atrial fibrillation substantially increases after 70 years of age. However, the effect of rate-control versus rhythm-control strategies on outcomes in these patients remains unclear. METHODS: In the randomized Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial, 4060 patients (mean age 70 years, range 49-80 years) with paroxysmal and persistent atrial fibrillation were randomized to rate-control versus rhythm-control strategies. Of these, 2248 were 70-80 years, of whom 1118 were in the rate-control group. Propensity scores for rate-control strategy were estimated for each of the 2248 patients and were used to assemble a cohort of 937 pairs of patients receiving rate-control versus rhythm-control strategies, balanced on 45 baseline characteristics. RESULTS: Matched patients had a mean age of 75 years; 45% were women, 7% were nonwhite, and 47% had prior hospitalizations due to arrhythmias. During 3.4 years of mean follow-up, all-cause mortality occurred in 18% and 23% of matched patients in the rate-control and rhythm-control groups, respectively (hazard ratio [HR] associated with rate control, 0.77; 95% confidence interval [CI], 0.63-0.94; P = .010). HRs (95% CIs) for cardiovascular and noncardiovascular mortality associated with rate control were 0.88 (0.65-1.18) and 0.62 (0.46-0.84), respectively. All-cause hospitalization occurred in 61% and 68% of rate-control and rhythm-control patients, respectively (HR 0.76; 95% CI, 0.68-0.86). HRs (95% CIs) for cardiovascular and noncardiovascular hospitalization were 0.66 (0.56-0.77) and 1.07 (0.91-1.27), respectively. CONCLUSION: In septuagenarian patients with atrial fibrillation, compared with rhythm-control, a rate-control strategy was associated with significantly lower mortality and hospitalization.
Authors: D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley Journal: N Engl J Med Date: 2002-12-05 Impact factor: 91.245
Authors: Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns Journal: N Engl J Med Date: 2002-12-05 Impact factor: 91.245
Authors: Yan Zhang; Meredith L Kilgore; Tarun Arora; Marjan Mujib; O James Ekundayo; Inmaculada B Aban; Margaret A Feller; Ravi V Desai; Thomas E Love; Richard M Allman; Gregg C Fonarow; Ali Ahmed Journal: Int J Cardiol Date: 2011-11-25 Impact factor: 4.164
Authors: Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse Journal: Circulation Date: 2004-03-08 Impact factor: 29.690
Authors: Andrew E Epstein; Humberto Vidaillet; H Leon Greene; Anne B Curtis; Kenneth A Ellenbogen; Todd Simmons; Mary Mickel Journal: J Cardiovasc Electrophysiol Date: 2002-07
Authors: Frederick A Masoudi; Edward P Havranek; Pam Wolfe; Cary P Gross; Saif S Rathore; John F Steiner; Diana L Ordin; Harlan M Krumholz Journal: Am Heart J Date: 2003-08 Impact factor: 4.749
Authors: Elizabeth S Kaufman; Paul A Zimmermann; Ted Wang; George W Dennish; Patrick D Barrell; Mary L Chandler; H Leon Greene Journal: J Am Coll Cardiol Date: 2004-09-15 Impact factor: 24.094
Authors: Waqas Qureshi; Elsayed Z Soliman; Scott D Solomon; Alvaro Alonso; Dan E Arking; Amil Shah; Deepak K Gupta; Lynne E Wagenknecht; David Herrington Journal: Am J Cardiol Date: 2014-08-18 Impact factor: 2.778
Authors: Lu-Chen Weng; Kathryn L Lunetta; Martina Müller-Nurasyid; Albert Vernon Smith; Sébastien Thériault; Peter E Weeke; John Barnard; Joshua C Bis; Leo-Pekka Lyytikäinen; Marcus E Kleber; Andreas Martinsson; Henry J Lin; Michiel Rienstra; Stella Trompet; Bouwe P Krijthe; Marcus Dörr; Derek Klarin; Daniel I Chasman; Moritz F Sinner; Melanie Waldenberger; Lenore J Launer; Tamara B Harris; Elsayed Z Soliman; Alvaro Alonso; Guillaume Paré; Pedro L Teixeira; Joshua C Denny; M Benjamin Shoemaker; David R Van Wagoner; Jonathan D Smith; Bruce M Psaty; Nona Sotoodehnia; Kent D Taylor; Mika Kähönen; Kjell Nikus; Graciela E Delgado; Olle Melander; Gunnar Engström; Jie Yao; Xiuqing Guo; Ingrid E Christophersen; Patrick T Ellinor; Bastiaan Geelhoed; Niek Verweij; Peter Macfarlane; Ian Ford; Jan Heeringa; Oscar H Franco; André G Uitterlinden; Uwe Völker; Alexander Teumer; Lynda M Rose; Stefan Kääb; Vilmundur Gudnason; Dan E Arking; David Conen; Dan M Roden; Mina K Chung; Susan R Heckbert; Emelia J Benjamin; Terho Lehtimäki; Winfried März; J Gustav Smith; Jerome I Rotter; Pim van der Harst; J Wouter Jukema; Bruno H Stricker; Stephan B Felix; Christine M Albert; Steven A Lubitz Journal: Sci Rep Date: 2017-09-12 Impact factor: 4.379